Target
Proto-oncogene tyrosine-protein kinase receptor Ret [V804L]
Ligand
BDBM434997
Substrate
n/a
Meas. Tech.
RET V804L Gatekeeper Mutant Assay at KM
IC50
1250±n/a nM
Citation
 Brubaker, JDKim, JLWilson, KJWilson, DDiPietro, LV Inhibitors of RET US Patent  US10584114 Publication Date 3/10/2020 
Target
Name:
Proto-oncogene tyrosine-protein kinase receptor Ret [V804L]
Synonyms:
CDHF12 | CDHR16 | PTC | RET | RET kinase (V804L) | RET kinase mutant (V804L) | RET51 | RET_HUMAN
Type:
Enzyme Catalytic Domain
Mol. Mass.:
124332.32
Organism:
Homo sapiens (Human)
Description:
P07949[V804L]
Residue:
1114
Sequence:
MAKATSGAAGLRLLLLLLLPLLGKVALGLYFSRDAYWEKLYVDQAAGTPLLYVHALRDAPEEVPSFRLGQHLYGTYRTRLHENNWICIQEDTGLLYLNRSLDHSSWEKLSVRNRGFPLLTVYLKVFLSPTSLREGECQWPGCARVYFSFFNTSFPACSSLKPRELCFPETRPSFRIRENRPPGTFHQFRLLPVQFLCPNISVAYRLLEGEGLPFRCAPDSLEVSTRWALDREQREKYELVAVCTVHAGAREEVVMVPFPVTVYDEDDSAPTFPAGVDTASAVVEFKRKEDTVVATLRVFDADVVPASGELVRRYTSTLLPGDTWAQQTFRVEHWPNETSVQANGSFVRATVHDYRLVLNRNLSISENRTMQLAVLVNDSDFQGPGAGVLLLHFNVSVLPVSLHLPSTYSLSVSRRARRFAQIGKVCVENCQAFSGINVQYKLHSSGANCSTLGVVTSAEDTSGILFVNDTKALRRPKCAELHYMVVATDQQTSRQAQAQLLVTVEGSYVAEEAGCPLSCAVSKRRLECEECGGLGSPTGRCEWRQGDGKGITRNFSTCSPSTKTCPDGHCDVVETQDINICPQDCLRGSIVGGHEPGEPRGIKAGYGTCNCFPEEEKCFCEPEDIQDPLCDELCRTVIAAAVLFSFIVSVLLSAFCIHCYHKFAHKPPISSAEMTFRRPAQAFPVSYSSSGARRPSLDSMENQVSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLILEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKRRDYLDLAASTPSDSLIYDDGLSEEETPLVDCNNAPLPRALPSTWIENKLYGMSDPNWPGESPVPLTRADGTNTGFPRYPNDSVYANWMLSPSAAKLMDTFDS
  
Inhibitor
Name:
BDBM434997
Synonyms:
US10584114, Compound 110 | US11279688, Compound 110
Type:
Small organic molecule
Emp. Form.:
C27H31FN8O
Mol. Mass.:
502.5864
SMILES:
C[C@H](NC(=O)[C@H]1CC[C@H](CC1)c1cc(C)cc(Nc2cc(C)[nH]n2)n1)c1ccc(nc1)-n1cc(F)cn1 |r,wU:1.0,wD:8.11,5.4,(4,4.24,;4,2.7,;2.67,1.93,;1.33,2.7,;1.33,4.24,;,1.93,;-1.33,2.69,;-2.67,1.93,;-2.67,.38,;-1.33,-.38,;,.38,;-4,-.39,;-4,-1.93,;-5.33,-2.7,;-5.33,-4.24,;-6.67,-1.93,;-6.67,-.39,;-8,.38,;-9.34,-.39,;-10.74,.24,;-11.77,-.9,;-13.3,-.74,;-11,-2.24,;-9.5,-1.92,;-5.33,.38,;5.33,1.93,;6.67,2.7,;8,1.93,;8,.39,;6.67,-.38,;5.33,.39,;9.34,-.38,;10.74,.24,;11.77,-.9,;13.3,-.74,;11,-2.24,;9.5,-1.92,)|
Structure:
Search PDB for entries with ligand similarity: